CBD shows benefit as adjunctive therapy in adults with drug-resistant focal epilepsy
A version of this article was originally published on NeurologyLive. This version has been slightly edited. In a recently published prospective observational study, the use of cannabidiol (CBD; Epidiolex; Genentech) as an adjuvant treatment was effective, safe, and associated with significant improvements in quality of life in adults with drug-resistant focal epilepsy. Improvements in quality…
Read More “CBD shows benefit as adjunctive therapy in adults with drug-resistant focal epilepsy” »